HHS Drug Pricing Plan: Mum On National Cost Effectiveness Program, Cautious On QALYs

Administration Has Yet To Describe How To Define Drug Value • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet